Neuronetics Inc
NASDAQ:STIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuronetics Inc
NASDAQ:STIM
|
US |
|
Apator SA
F:8QM
|
PL |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
Almonty Industries Inc
NASDAQ:ALM
|
CA |
|
Bank First Corp
NASDAQ:BFC
|
US |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
Intrinsic Value
Is STIM undervalued or overvalued?
See the intrinsic value estimate for
Neuronetics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
STIM looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with STIM’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Neuronetics Does
Neuronetics makes and sells the NeuroStar system, a medical device used by doctors to treat major depressive disorder and certain other mental health conditions without surgery or drugs. The company’s main customers are outpatient psychiatry clinics, hospitals, and other providers that offer brain stimulation therapy to patients who have not responded well to medication alone.
- Headquarters
- United States of America US
- Employees
- 658
- IPO date
- Jun 28, 2018
Revenue & Expenses Breakdown
Neuronetics Inc
Earnings Waterfall
Neuronetics Inc
The intrinsic value for
Neuronetics Inc (STIM) under the Base Case is hidden USD.
Compared with the current market price of 2.24 USD, the stock appears hidden.